{"id":"W2035278640","doi":"10.1016/j.leukres.2014.10.005","title":"Comparative efficacy of tyrosine kinase inhibitor treatments in the third-line setting, for chronic-phase chronic myelogenous leukemia after failure of second-generation tyrosine kinase inhibitors","year":2014,"lang":"en","type":"review","venue":"Leukemia Research","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":57,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"Pfizer","keywords":"Bosutinib; Ponatinib; Nilotinib; Dasatinib; Medicine; Tyrosine kinase; Chronic myelogenous leukemia; Tyrosine-kinase inhibitor; Internal medicine; Imatinib; Pharmacology; Oncology; Leukemia; Myeloid leukemia","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0009334032,0.000560392,0.002421291,0.00123461,0.0001218768,0.0007922231,0.0008689471,0.0006016722,0.00257522],"category_scores_gemma":[0.001218121,0.0001954718,0.001582922,0.001423157,0.0002262716,0.0005844677,0.0002909049,0.0009970721,0.0003667376],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0005097156,"about_ca_system_score_gemma":0.0008624192,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001125177,"about_ca_topic_score_gemma":0.003325295,"domain_scores_codex":[0.9997706,0.00005478948,0.00005699335,0.00003672121,0.00006463725,0.00001637353],"domain_scores_gemma":[0.9994491,0.0003532432,0.0001121346,0.000008026735,0.0000620766,0.00001543203],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.001491746,0.0001564201,0.0003603061,0.1003849,0.001773571,0.0001171441,0.00005257767,0.0004798548,0.001558461,0.001305846,0.008268052,0.8840511],"study_design_scores_gemma":[0.003092865,0.004075853,0.01328149,0.07798505,0.02002621,0.002955189,0.0003369882,0.0005955535,0.002984719,0.002677638,0.8718508,0.0001376873],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.0003257062,0.9993019,0.00002874338,0.00004131849,0.00003658895,0.000006232528,0.00002928512,0.000001444418,0.0002288398],"genre_scores_gemma":[0.002757725,0.9967585,0.0001372867,0.0001166381,0.00004303274,0.000008454615,0.00005385997,8.921455e-7,0.0001236534],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00257522,"threshold_uncertainty_score":0.008614957,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.08836413084802916,"score_gpt":0.4135965523823236,"score_spread":0.3252324215342944,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}